Blog

Mylan says Teva offer too low and stock 'unacceptable'

Mylan, which is pursuing its own takeover of Perrigo Co Plc, had been expected to reject the offer after having indicated that such a combination would not be a good fit. Wall Street analysts had said Mylan might be looking for $90 to $95 per share and an increased cash component. Coury said in the letter, which described Teva’s culture as “dysfunctional,” that Teva’s stock was an unacceptable currency because